Speaker illustration

Doctor Anastasiia Solonovych

Heart Institute of the Ministry of Healthcare of Ukraine, Kiev (Ukraine)

Cognitive function and adherence to treatment in patients with chronic heart failure and reduced left ventricular ejection fraction: relation and prognostic meaning

Event: ESC Congress 2019

Topic: Comorbidities

Session: Heart failure: aspects of aging and cognition

Thumbnail

New disease-specific adherence questionnaire can predict 2-year survival in chronic heart failure

Event: ESC Congress 2019

Topic: Comorbidities

Session: Heart failure management

Thumbnail

Prognostic value of cognitive tests in chronic heart failure with reduced left ventricular ejection fraction

Event: Heart Failure 2019

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Thumbnail

Predictors of cognitive impairment in patients with chronic heart failure and reduced left ventricular ejection fraction

Event: Heart Failure 2019

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Thumbnail

Meldonium and gamma-butyrobetaine combination improves cognitive function and flow-mediated vasodilatory response in chronic systolic heart failure: the results of open-label pilot study.

Event: Heart Failure 2018

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

Cognitively impaired versus cognitively non-impaired chronic heart failure patients: which distinctions?

Event: Heart Failure 2018

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb